Giles to sell off life sciences business
Giles Insurance Brokers is to sell its life sciences business as it looks to focus on its more traditional lines of business.
Giles said the sale formed part of the strategy within the company to focus on key growth areas including general commercial as well as specialisms such as professional indemnity, charities, motor trade, golf and transport comprising bus, coach, haulage, fleet and couriers.
Sarah Lyons, Giles group managing director, commented: “Giles is focused on developing its core business through organic growth and acquisition. We benefit from being a well-regarded commercial broker with a series of strong
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.
You are currently unable to print this content. Please contact info@insuranceage.co.uk to find out more.
You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@insuranceage.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@insuranceage.co.uk
Most read
- In Depth: Managing cyber risk in an ever-changing security landscape
- Covéa cuts losses but underwriting deficit grows
- JMG strikes its biggest deal of 2024 with BQI swoop